5AM Ventures VII, L.P. — SEC insider filings

SEC reporting owner CIK 1844435. 9 insider filings on record with FilingPulse; latest filed 2026-09-24.

Transaction summary — filings shown

Covers all 9 filings on record, filed 2024-02-02 to 2026-09-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Skye Bioscience, Inc. (SKYE)10% owner72 legs · 5,656,074 sh · $16,526,03125 legs · 1,055,553 sh · $2,995,503—
Camp4 Therapeutics Corp (CAMP)10% owner21 leg · 2,941,176 sh · $4,499,999—1

Insider filings — 5AM Ventures VII, L.P.

FiledFormIssuerReported transactionsSource
2026-09-244Skye Bioscience, Inc. (SKYE)
jointly with 5AM Partners VII, LLC, 5AM Partners II, LLC, 5AM Ventures II LP, 5AM CO-INVESTORS II LP, DIEKMAN JOHN D, PARMAR KUSH, ROCKLAGE SCOTT M
Sale (S): 27,612 @ $1.65 · Sale (S): 1,088 @ $1.65 · Sale (S): 114,851 @ $1.61 · Sale (S): 4,528 @ $1.61EDGAR
2026-09-184Skye Bioscience, Inc. (SKYE)
jointly with 5AM Partners VII, LLC, 5AM Partners II, LLC, 5AM Ventures II LP, 5AM CO-INVESTORS II LP, DIEKMAN JOHN D, PARMAR KUSH, ROCKLAGE SCOTT M
Sale (S): 32,607 @ $1.91 · Sale (S): 1,285 @ $1.91EDGAR
2026-08-204Skye Bioscience, Inc. (SKYE)
jointly with 5AM Partners VII, LLC, 5AM Partners II, LLC, 5AM Ventures II LP, 5AM CO-INVESTORS II LP, DIEKMAN JOHN D, PARMAR KUSH, ROCKLAGE SCOTT M
Sale (S): 45,090 @ $0.38 · Sale (S): 1,830 @ $0.38 · Sale (S): 253,080 @ $0.38 · Sale (S): 10,255 @ $0.35 · Sale (S): 409 @ $0.35 · Sale (S): 57,476 @ $0.35 · +3 moreEDGAR
2026-08-054Camp4 Therapeutics Corp (CAMP)
jointly with 5AM Partners VI, LLC, 5AM Ventures VI, L.P., 5AM Opportunities II (GP), LLC, 5AM Opportunities II, L.P., 5AM Partners VII, LLC, PARMAR KUSH
Purchase (P): 3,179,558 (derivative) @ $1.53EDGAR
2025-09-154Camp4 Therapeutics Corp (CAMP)
jointly with 5AM Partners VI, LLC, 5AM Ventures VI, L.P., 5AM Opportunities II (GP), LLC, 5AM Opportunities II, L.P., 5AM Partners VII, LLC, PARMAR KUSH
Purchase (P): 2,941,176 @ $1.53EDGAR
2025-08-224Skye Bioscience, Inc. (SKYE)
jointly with 5AM Partners VII, LLC, 5AM Partners II, LLC, 5AM Ventures II LP, 5AM CO-INVESTORS II LP, DIEKMAN JOHN D, PARMAR KUSH, ROCKLAGE SCOTT M
Sale (S): 58,642 @ $3.57 · Sale (S): 2,314 @ $3.57 · Sale (S): 163,979 @ $3.42 · Sale (S): 6,470 @ $3.42EDGAR
2024-09-134Skye Bioscience, Inc. (SKYE)
jointly with 5AM Partners VII, LLC, 5AM Partners II, LLC, 5AM Ventures II LP, 5AM CO-INVESTORS II LP, DIEKMAN JOHN D, PARMAR KUSH, ROCKLAGE SCOTT M
Sale (S): 214,556 @ $6.60 · Sale (S): 36,504 @ $6.60 · Sale (S): 1,440 @ $6.60 · Sale (S): 11,758 @ $6.06 · Sale (S): 2,000 @ $6.06 · Sale (S): 79 @ $6.06EDGAR
2024-03-154Skye Bioscience, Inc. (SKYE)
jointly with 5AM Partners VII, LLC, 5AM Partners II, LLC, 5AM Ventures II LP, 5AM CO-INVESTORS II LP, DIEKMAN JOHN D, PARMAR KUSH, ROCKLAGE SCOTT M
Purchase (P): 450,000 @ $10EDGAR
2024-02-024Skye Bioscience, Inc. (SKYE)
jointly with 5AM Partners VII, LLC, 5AM Partners II, LLC, 5AM Ventures II LP, 5AM CO-INVESTORS II LP, DIEKMAN JOHN D, PARMAR KUSH, ROCKLAGE SCOTT M
Purchase (P): 5,206,074 @ $2.31EDGAR

FilingPulse's Form 4 archive currently extends back to 2022-05-23 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1844435 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs